ICARIA-MM study: efficacy analysis according to prior lines of treatment

dc.contributor.authorBringhen, Sara
dc.contributor.authorAttal, Michel
dc.contributor.authorPour, Ludek
dc.contributor.authorVorobyev, Vladimir
dc.contributor.authorVural, Filiz
dc.contributor.authorWarzocha, Krzysztof
dc.contributor.authorRichardson, Paul G.
dc.date.accessioned2020-12-01T12:09:12Z
dc.date.available2020-12-01T12:09:12Z
dc.date.issued2019
dc.departmentEge Üniversitesien_US
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1016/j.clml.2019.09.407
dc.identifier.endpageE246en_US
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.issue10en_US
dc.identifier.startpageE245en_US
dc.identifier.urihttps://doi.org/10.1016/j.clml.2019.09.407
dc.identifier.urihttps://hdl.handle.net/11454/63357
dc.identifier.volume19en_US
dc.identifier.wosWOS:000491229800404en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherCig Media Group, Lpen_US
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemiaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCD38en_US
dc.subjectMultiple myelomaen_US
dc.subjectRelapsed/Refractoryen_US
dc.titleICARIA-MM study: efficacy analysis according to prior lines of treatmenten_US
dc.typeConference Objecten_US

Dosyalar